Treatment with tofacitinib attenuates muscle loss through myogenin activation in the collagen-induced arthritis.
da Rosa TH, Bartikoski BJ, do Espírito Santo RC, Farinon M, de Souza Silva JM, Pedó RT, Gasparini ML, Karnopp T, Dos Santos LP, Chapacais G, di Domenico A, Loch S, Xavier RM.
da Rosa TH, et al. Among authors: loch s.
Adv Rheumatol. 2024 Nov 13;64(1):85. doi: 10.1186/s42358-024-00416-5.
Adv Rheumatol. 2024.
PMID: 39538350